The trail enrolled 123 patients at 23 sites across the US and Europe.

Jupiter Endovascular announced that it completed patient enrollment in the SPIRARE II pivotal clinical trial evaluating its Vertex system.

AngioDynamics, Inc. and The PERT Consortium announced the launch of the ALPHA-PE Research Fund, an investigator-led initiative ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

The Vertex Pulmonary Embolectomy System with Endoportal Control (TM) is designed to treat Acute Pulmonary Embolism (PE) in an innovative endovascular procedure offering an unprecedented level of ...

Pulmonary embolism (PE) is a common and potentially life-threatening condition with presentations ranging from mild symptoms to circulatory collapse. Early and accurate risk stratification is ...

CORPUS CHRISTI, Texas — A local procedure is now available here in Corpus Christi for high-risk patients with pulmonary embolism. Pulmonary embolism is a blockage in one of the pulmonary arteries in ...

MIAMI BEACH, FL—Pulmonary embolism (PE), an often-deadly condition that’s best served by a multidisciplinary approach to care, is the perfect target for artificial intelligence (AI), according to ...

Please provide your email address to receive an email when new articles are posted on . Models included age, sex, BMI, anticoagulant use and prior pulmonary embolism (PE), chronic lung disease and ...

Dublin, Dec. 19, 2025 (GLOBE NEWSWIRE) -- The "Pulmonary Embolism Market - A Global and Regional Analysis, 2025-2035" has been added to ResearchAndMarkets.com's offering. The global pulmonary embolism ...

Exercise rehabilitation may confer functional improvements to patients struggling to breathe following a pulmonary embolism (PE), a randomized controlled trial found. Patients with persistent dyspnea ...